Browse
Submit Data
Databases
API
Help

Dataset Information

7 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Clinical research for San-Wu-Huang-Qin decoction in the prevention and treatment of recurrence of colorectal adenoma

ABSTRACT: Interventions: Experimental group:Sanwu Huangqin decoction;control group:placebo Primary outcome(s): Recurrence rate of adenoma Study Design: Parallel

DISEASE(S): Colorectal Adenoma

PROVIDER: 2692741 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Sijunzi decoction on prevention and treatment of recurrence of colorectal adenoma after resection: a multicenter, randomized controlled trial

Project description:Interventions: Sijunzi Decotion Group:Sijunzi Decoction formula granules are taken orally, one tablet at a time, twice a day. The course of treatment is 12 months.;Placebo Group:Placebo granules are taken orally, one tablet at a time, twice a day. The course of treatment is 12 months. Primary outcome(s): The recurrence rate of colorectal adenoma Study Design: Parallel

| 80551 | ecrin-mdr-crc

Clinical study on the prevention and treatment of colorectal adenoma by regulating intestinal microecology: a randomized double-blind controlled trial

Project description:Interventions: experimental group 1:Yiyi Fuzi Baijiang Powder;experimental group 2:Sanwu Huangqin Decoction;placebo group 1:Yiyi Fuzi Baijiang Powder placebo agent;placebo group 2:Sanwu Huangqin Decoction placebo agent Primary outcome(s): recurrence rate Study Design: Parallel

| 2693768 | ecrin-mdr-crc

Plant microRNA profiling of Honeysuckle and Honeysuckle Decoction

Project description:Influenza A viruses (IAVs), particularly H1N1, H5N1 and H7N9, pose a substantial threat to public health worldwide. Here, we report that MIR2911, a honeysuckle (HS)-encoded atypical microRNA, directly targets IAVs with a broad spectrum. MIR2911 is highly stable in HS decoction, and continuous drinking or gavage feeding of HS decoction leads to a significant elevation of the MIR2911 level in mouse peripheral blood and lung. Bioinformatics prediction and a luciferase reporter assay showed that MIR2911 could target various IAVs, including H1N1, H5N1 and H7N9. Synthetic MIR2911 significantly inhibited H1N1-encoded PB2 and NS1 protein expression but did not affect mutants in which the MIR2911-binding nucleotide sequences were altered. Synthetic MIR2911, extracted RNA from HS decoction and HS decoction all significantly inhibited H1N1 viral replication and improved viral infection-induced mouse weight loss but did not affect infection with a mutant virus in which the MIR2911-binding nucleotide sequences of PB2 and NS1 were altered. Importantly, the inhibitory effect of HS decoction on viral replication was abolished by an anti-MIR2911 antagomir, indicating that the physiological concentration of MIR2911 in HS decoction could directly and sufficiently suppress H1N1 viral replication. MIR2911 also inhibited H5N1 and H7N9 viral replication in vitro and in vivo. Strikingly, administration of MIR2911 or HS decoction both dramatically reduced mouse mortality caused by H5N1 infection. Our results demonstrate that MIR2911 is the first active component identified in Traditional Chinese Medicine to directly target various IAVs and may represent a novel type of natural product that effectively suppresses viral infection. Screening and profiling of known plant microRNA in HS and HS decoction

2014-10-22 | E-GEOD-55268 | biostudies-arrayexpress

Gene expression biomarkers discovery for the Sini Decoction Pattern

Project description:We aimed to investigate the syndrome of Sini decoction pattern. The Sini decoction was first mentioned in Shang Han Za Bing Lun, then was developed into Sini decoction pattern (SDP) by Sun Simiao’s Qian Jin Yi Fang. The syndromes of SDP were correlated with various extremely Yang deficiency related symptoms, but there does not exist common definition.

2015-03-20 | GSE67090 | GEO

Identification of candidate targets for Haizao Yuhu Decoction acting on goiter rats

Project description:To predict the different genes, this study compared the gene expression level among the control group, the model group and the treatment groups. In this present study, 20 Wistar rats, weighting 160-180g and as the sex evenly, were randomly divided into five groups: normal control group, model control group , Haizao Yuhu decoction group, Haizao Yuhu decotion lacking Sargassum fusiforme (DL-S) group, and Haizao Yuhu decotion lacking Radix Glycyrrhiza (DL-G) group. Except the rats in control and model groups, the three other groups, which were established as goiter model, were administered appropriate medication at the dose of 1mL/100g for 28 consecutive days. After all animals sacrificed, thyroids were removed and then put in Trizol for microarray experiments.

2016-01-20 | E-GEOD-76817 | biostudies-arrayexpress

The Research of Gegen Qinlian Decoction Improves the Chemotherapy Effect of Damp-Heat Type Colorectal Cancer by Adjusting the Gut Microbiota

Project description:Interventions: experimental group:FOLFOX regimens and Gegen Qinlian Decoction;control group:FOLFOX regimens Primary outcome(s): gut microbiota;Contrast-enhanced CT/MRI of the abdomen Study Design: Parallel

| 2703554 | ecrin-mdr-crc

Plant microRNA profiling of Honeysuckle and Honeysuckle Decoction

2014-10-22 | GSE55268 | GEO

The effect and mechanism of Si-Jun-Zi decoction on the function of intestinal mucosal barrier during chemotherapy for colorectal cancer

Project description:Interventions: Control:FOLFOX or CAPEOX chemtherapy;Experimental group 1:Si-Jun-Zi decoction;Experimental group 2:enteral nutrition combine with Chemotherapy;Experimental group 3:Si-Jun-Zi decoction + enteral nutrition Primary outcome(s): Intestinal barrier function Study Design: Parallel

| 2689141 | ecrin-mdr-crc

Clinical effect of Jianpi Lishi Jiedu Decoction on postoperative patients with spleen deficiency and dampness toxin type colorectal adenoma

Project description:Interventions: The experimental group:Chinese medicine Jianpi Lishi Jiedu recipe, twice a day, 25ml each time, 1 hour after breakfast and dinner, course of 3 months;The control group:Follow up and observation Primary outcome(s): Main symptoms of Patiens;Curative effect of TCM Syndrome;Recurrence rate of colorectal adenoma;Safety indicators (such as routine hematuria feces, liver and kidney function, ECG);Beta-catenin Study Design: Parallel

| 2704459 | ecrin-mdr-crc

Development of gene expression signatures for Buyang Huanwu decoction in treating intracerebral hemorrhage

Project description:To identify the potential lncRNA and mRNA asscociated with Buyang Huanwu decoction (BYHWD) in treating intracerebral hemorrhage (ICH), we have employed lncRNA microarray expression profiling. 1596 and 1114 mRNAs were identified in the ICH vs sham group and the BYHWD vs ICH group, respectively. Specifically, 180 DEmRNAs were intersected among the three groups. 2287 and 2245 lncRNAs were identified in the ICH vs sham group and the BYHWD vs ICH group, respectively. Specifically, 342 DElncRNAs were intersected among the three groups. Expression of four mRNA (Spata2, Nkiras, Mef2c, Sh2b3) and lncRNA (Gm16045, Gm14005, Gm41118, 493304012Rik) from this signature was quantified by qPCR.

2023-07-01 | GSE220886 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data